Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 3NIH 1NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 16Lymphoid 8Breast 6Sarcoma 4Genitourinary 4CNS 3Plasma cell 2Other neoplasm 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Precancerous Conditions 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1

Interventions

Polymerase Chain Reaction 4Selenium 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Vitamin E 2Tacrolimus 2Radiotherapy, Intensity-Modulated 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Melphalan 2Light Coagulation 2Cytogenetic Analysis 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Busulfan 2alpha-Tocopherol 1Watchful Waiting 1Vaginal Smears 1Soybean Proteins 1Rosuvastatin Calcium 1Paclitaxel 1Moxifloxacin 1Morphine 1Microarray Analysis 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Microarray Analysis × Other neoplasm × Clear all
NCT00900263 2016-10-07

S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma

SWOG Cancer Research Network

Completed
375 enrolled
Other neoplasmPlasma cell

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡